These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 1157040

  • 1. Fast- and slow-growing transplantable tumors derived from spontaneous mammary tumors of the DBA/2 Ha-DD mouse.
    Hosokawa M, Orsini F, Mihich E.
    Cancer Res; 1975 Oct; 35(10):2657-62. PubMed ID: 1157040
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of the growth properties in vitro and transplantability of continuous mouse mammary tumor cell lines and clonal derivatives.
    Butel JS, Dudley JP, Medina D.
    Cancer Res; 1977 Jun; 37(6):1892-900. PubMed ID: 192465
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Therapeutic potential of biological response modifiers against transplantable mouse tumors of spontaneous origin. I. Characterization of biological properties of tumor lines and preliminary data on response to cytostatic drugs and biomodulators.
    Fiszer-Maliszewska L, Mordarski M, Madej JA.
    Arch Immunol Ther Exp (Warsz); 1993 Jun; 41(1):1-9. PubMed ID: 8239902
    [Abstract] [Full Text] [Related]

  • 7. Growth interaction in vivo between tumor subpopulations derived from a single mouse mammary tumor.
    Miller BE, Miller FR, Leith J, Heppner GH.
    Cancer Res; 1980 Nov; 40(11):3977-81. PubMed ID: 7471048
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Therapeutic potential of biological response modifiers against transplantable mouse tumors of spontaneous origin. II. Local interleukin 2 treatment of tumors of different immunogenic strength.
    Fiszer-Maliszewska L, Den Otter W, Madej JA, Mordarski M.
    Arch Immunol Ther Exp (Warsz); 1998 Nov; 46(5):293-300. PubMed ID: 9832068
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Relationship between tumor growth characteristics and preferential sites of growth.
    Vaage J.
    J Natl Cancer Inst; 1984 May; 72(5):1199-203. PubMed ID: 6585595
    [Abstract] [Full Text] [Related]

  • 13. Changing transplantation characteristics with serial in vivo passage of C3H/He mammary carcinomas.
    Vaage J.
    Cancer Res; 1978 Oct; 38(10):3264-8. PubMed ID: 688216
    [Abstract] [Full Text] [Related]

  • 14. [MA891--an established spontaneous mouse mammary adenocarcinoma cell line and its immunologic characteristics].
    Zhou Y, Luo L, Liu X, Gao P, Su Y.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Aug; 19(4):273-7. PubMed ID: 10453566
    [Abstract] [Full Text] [Related]

  • 15. Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells.
    Chen PW, Kaba DS, Ananthaswamy HN.
    Cancer Res; 1990 Mar 01; 50(5):1544-9. PubMed ID: 2137370
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Isolation and characterization of clonal cell lines from a transplantable metastasizing rat mammary tumor, TR2CL.
    Williams JC, Gusterson BA, Monaghan P, Coombes RC, Rudland PS.
    J Natl Cancer Inst; 1985 Feb 01; 74(2):415-28. PubMed ID: 2579259
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Immunity to a TA3 tumor subline that grows in allogeneic hosts elicited by strain-specific TA3 tumor cells.
    Lippman MM, Venditti JM, Kline I, Elam DL.
    Cancer Res; 1973 Apr 01; 33(4):679-84. PubMed ID: 4696468
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.